Neuralink
Neuralink raises $650M Series D at $8B valuation
Quick Facts
Neuralink: Series D Funding Round
Neuralink has successfully raised $650M in Series D funding, reaching a valuation of $8B.
Company Overview
Brain-computer interface technology
Funding Details
The Series D round was led by Founders Fund, with participation from DFJ Growth.
Company Information
- Headquarters: Fremont, CA
- Founded: 2016
- Employees: 400+
- Category: Biotech
Investment
Neuralink plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Founders Fund: Verified investor in Series D
- DFJ Growth: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
